P.S. Sanofi manufacturers docetaxel.
http://www.fiercebiotech.com/story/sanofi-ink...2010-06-04
"Mel Sorensen, president and CEO of Ascenta. "Restoring tumor suppressor function through the inhibition of the HDM2-p53 interaction offers the potential to control and prevent cancer progression."